Ascentage Pharma Group International (NASDAQ:AAPG – Get Free Report) shares rose 5.1% on Tuesday . The company traded as high as $23.30 and last traded at $23.07. Approximately 7,171 shares were traded during trading, a decline of 91% from the average daily volume of 82,682 shares. The stock had previously closed at $21.95.
Analyst Ratings Changes
Separately, JPMorgan Chase & Co. began coverage on shares of Ascentage Pharma Group International in a research note on Thursday, March 27th. They issued an “overweight” rating for the company.
Get Our Latest Stock Report on AAPG
Ascentage Pharma Group International Trading Down 0.2 %
Ascentage Pharma Group International Company Profile
Ascentage Pharma Group International Co, Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.
See Also
- Five stocks we like better than Ascentage Pharma Group International
- Insider Selling Explained: Can it Inform Your Investing Choices?
- 5 Reasons Why Halliburton is a Good Buy in 2025
- The How And Why of Investing in Oil Stocks
- Homebuilders in Freefall: Bargain Opportunity or Falling Knife?
- What is MarketRank™? How to Use it
- The 3 Most Talked About Investments on WallStreetBets Right Now
Receive News & Ratings for Ascentage Pharma Group International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascentage Pharma Group International and related companies with MarketBeat.com's FREE daily email newsletter.
